Diabetes Care Services
In the US clinics, experienced endocrinologists and surgeons are engaged in the treatment of diabetes mellitus. The therapy itself is based on the use of the latest developments in the world of pharmaceuticals – innovative long-acting drugs, new substances that accelerate the absorption of short-acting drugs, as well as compounds that delay the disease’s development. To improve the assimilation of medicines, modern devices are used here – subcutaneously implanted automatic syringes, INSUPATCH devices heating the injection site, JET INJECTION – injection devices. In parallel with this, “smart” syringes are used, which themselves measure and control the level of sugar in the blood.
Constant developments in the field of diabetes treatment in the United States are due to the global scale of the problem in the country. Thus, according to statistics, more than 35 million American adults suffer from the disease, which is more than 10% of the total population. Another 87 million people have prediabetes. Mortality from the disease ranks 7th among the main causes of death.
How diabetes is cured in the USA?
A number of innovative technologies are used to provide diabetes care services:
- transplantation of Langerhans islets. The method is based on the transplantation of tissues into the pancreas of the patient, which are responsible for the production of insulin. This method has already proved its effectiveness. If this technique is combined with the transplantation of stem cells that activate immune processes, you can get rid of the need for injections.
- pancreatic transplantation. This method has been used in the USA for the treatment of type 1 diabetes for more than 20 years and has already become traditional, but in the US healthcare system it has received new vectors of development. Thus, the best transplant specialists work in the leading medical centers in Boston and Phoenix, there is a large donor base, effective rehabilitation strategies after interventions are provided.
- bioengineering – transplantation of BioHUB (a created mini-organ of the pancreas). It is an artificially created platform of Langerhans islets, which are responsible for the production of insulin in exactly the right amounts for the body and at the same time protects itself from the immune system. The BioHUB creation technology can be based on the patient’s plasma or a synthetic porous material, also saturated with oxygen generators and helper cells.
Among the innovative developments, the latest PEC-Direct implants, which contain tissues grown from stem cells, should be noted. The product is of the size of a credit card, It is implanted into the patient’s body subcutaneously, independently producing insulin when it becomes necessary. This method is mainly used for the treatment of patients with type 1 diabetes.